Dementia is the umbrella term for all kinds of conditions associated with memory loss of which Alzheimer’s disease is the ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

However, the frequency of your nightmares, and how old you are when you experience them, might reveal information about your ...

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence the progression of neurodegeneration remains something of a black box ...

The interim phase 2 trial results show a good immune response in participants and the therapy is well tolerated to date.

People may also refer to DLB as Lewy body dementia (LBD), but DLB is just one type of LBD. Parkinson’s disease dementia (discussed below) is the other type. People with DLB may also: experience ...

Dementia is a debilitating neurodegenerative disease that gradually diminishes life quality, leading to memory loss, ...

Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

Researchers at Washington University School of Medicine in St. Louis have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer’s genesis and ...